The chemical class known as PDE4C activators encompasses a diverse array of compounds that modulate the activity of phosphodiesterase 4C, a crucial enzyme involved in the regulation of cyclic adenosine monophosphate (cAMP) levels within cells. Activators of this class are natural occurring diterpenes that initiate the adenylate cyclase pathway. Through stimulation of adenylate cyclase, activators trigger the conversion of adenosine triphosphate (ATP) to cAMP, leading to an elevated intracellular cAMP concentration. This heightened cAMP level serves as a pivotal signal for PDE4C activation, as the enzyme recognizes cAMP as its substrate for hydrolysis. PDE4C facilitate cAMP production underscores its role as a potent activator of PDE4C and emphasizes the intricate interplay between natural compounds and cellular signaling pathways.
Furthermore, activators contribute to the chemical repertoire of PDE4C activators. These compounds share the ability to mimic cAMP, serving as cell-permeable analogs that directly engage PDE4C by offering themselves as substrates for hydrolysis. In parallel, activators of this class indirectly promote PDE4C by disrupting the degradation of cAMP. The chemical diversity within this class highlights the multifaceted nature of PDE4C regulation, showcasing the intricacies involved in modulating intracellular cyclic nucleotide signaling. Understanding the molecular mechanisms of these activators not only sheds light on PDE4C function but also provides insights into the broader cellular processes governed by cyclic nucleotide signaling pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, leading to increased cAMP levels, subsequently activating PDE4C by providing a substrate for hydrolysis. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective inhibitor of PDE4, indirectly activating PDE4C by preventing cAMP degradation, prolonging its intracellular effects. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that stimulates adenylate cyclase, elevating cAMP levels and activating PDE4C. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cell-permeable cAMP analog, directly activating PDE4C by mimicking the natural substrate and stimulating its hydrolytic activity. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-selective PDE inhibitor, raises cAMP levels, and indirectly activates PDE4C by preventing cAMP degradation. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Phosphodiesterase inhibitor that increases cAMP levels, indirectly activating PDE4C by inhibiting its degradation. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Membrane-permeable cAMP analog, directly activating PDE4C by serving as a substrate for hydrolysis. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibitor of cGMP-specific phosphodiesterases, indirectly activating PDE4C by allowing the accumulation of cAMP due to reduced degradation. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
PDE3 inhibitor that increases cAMP levels, indirectly activating PDE4C by preventing cAMP degradation. | ||||||
Vardenafil | 224785-90-4 | sc-362054 sc-362054A sc-362054B | 100 mg 1 g 50 g | $526.00 $735.00 $16653.00 | 7 | |
PDE5 inhibitor that increases cGMP levels, indirectly activating PDE4C by reducing the inhibitory effect of cGMP on PDE4. | ||||||